March 18th 2025
The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.
Current Status of Drug Delivery Technologies and Future Directions
February 2nd 2001Evolution of an existing drug molecule from a conventional form to a novel delivery system can significantly improve its performance in terms of patient compliance, safety, and efficacy. These days,drug delivery companies are engaged in the development of multiple platform technologies to get competitive advantage, extend patent life, and increase market share of their products.